Location History:
- Oxfordshire, GB (2004)
- Oxford, GB (2013 - 2018)
Company Filing History:
Years Active: 2004-2018
Title: Scott David Gorman: Innovator in Antibody Technology
Introduction
Scott David Gorman is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of altered antibodies. With a total of 3 patents to his name, Gorman's work has the potential to impact various medical applications.
Latest Patents
Gorman's latest patents focus on the production of altered antibody chains. One of his key innovations involves creating an altered antibody chain where the complementarity-determining regions (CDRs) of the variable domain are derived from a first mammalian species. The framework-encoding regions of DNA that encode the variable domain of the first species are mutated to produce a framework derived from a second different mammalian species. Additionally, the constant domains of the antibody chain, if present, are also derived from the second mammalian species. This innovative approach could lead to advancements in therapeutic antibodies.
Career Highlights
Throughout his career, Scott David Gorman has worked with prominent companies in the biotechnology sector. He has been associated with Btg International Limited and Glaxo Wellcome Inc., where he has contributed to various research initiatives. His expertise in antibody technology has positioned him as a valuable asset in the field.
Collaborations
Gorman has collaborated with notable professionals in his field, including Michael Ronald Clark and Herman Waldmann. These collaborations have likely enriched his research and contributed to the advancements in antibody technology.
Conclusion
Scott David Gorman's innovative work in altered antibodies showcases his commitment to advancing biotechnology. His patents and collaborations reflect his significant contributions to the field, making him a noteworthy inventor in the realm of medical research.